Skip to main content
. 2022 Aug 15;9:959738. doi: 10.3389/fmolb.2022.959738

FIGURE 3.

FIGURE 3

Expression of ARNTL in different stages of AML. (A). Gender, (B) race, (C) age, (D) WBC count, (E) FLT3 mutation, (F) PB blasts, (G) Time-dependent ROC curve of AML patients in the training group and (H) FAB classification, p < 0.05 is considered as significant. *p < 0.05, **p < 0.01.